US.DXCM · Dexcom

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.792975110490812,
        "turnoverUsdM": 220.12376052000002,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.DXCM",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 81.1772,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2,
        "rsi_score": 1,
        "macd_score": 2.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 5.6,
      "take_profit_price": 90.6187,
      "target_multiplier": 1.9,
      "technical_strength": 1.53,
      "take_profit_percent": 5.4
    },
    "positionPoints": 1.4,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.585950220981624,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 61.9,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 54.9,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 85.992,
    "ma50": 87.5702,
    "close": 85.98,
    "prevClose": 86.04,
    "avgVolume20": 3396979,
    "volumeRatio": 0.75,
    "changePercent": -0.07
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": 0.0006983240223463749,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 0.7432071563662543,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 0.553713560751007,
      "volat_points": 0,
      "day_range_pct": 0.013717143521749091,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 61.9,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 4.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 92,
        "contribution": 4.6
      },
      {
        "raw": 9.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 46,
        "contribution": 9.2
      },
      {
        "raw": 7.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 48,
        "contribution": 7.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.6,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 66,
        "contribution": 6.6
      },
      {
        "raw": 17.3,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 57.67,
        "contribution": 17.3
      },
      {
        "raw": 8,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 80,
        "contribution": 8
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 54.9,
    "details": [
      "基本面分析總分: 4.6/5分",
      "資金流分析總分: 9.2/20分",
      "市場環境分析總分: 7.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.6/10分",
      "技術信號分析總分: 17.3/30分",
      "情緒分析: 8/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 4.6,
      "資金流": 9.2,
      "市場環境": 7.2,
      "情緒分析": 8,
      "技術信號": 17.3,
      "風險管理": 6.6
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0.75,
          "roePoints": 0.75,
          "debtPoints": 0.5,
          "marginPoints": 0.6,
          "turnoverUsdM": 220.12376052000002,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 1.6,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.DXCM",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 19.99
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 741.36350415,
                "ma50": 726.6799998800001,
                "name": "QQQ",
                "close": 718.35999,
                "points": 0.4
              },
              "spy": {
                "ma20": 770.8329956499999,
                "ma50": 768.36619598,
                "name": "SPY",
                "close": 766.47998,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.792975110490812,
          "atrPoints": 3,
          "cciPoints": 1.6,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "優秀",
        "items": {
          "sentiment": {
            "score": 8,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "negativeHits": 0,
              "positiveHits": 5,
              "sentimentScoreRaw": 2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142846263,
                "url": "https://finnhub.io/api/news?id=0ee1d790ccd5098af623c3ed88bba15b9275f4278cb312b8c59a33d19b6a039b",
                "image": "https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp",
                "source": "ChartMill",
                "related": "DXCM",
                "summary": "DexCom (DXCM) offers affordable growth with strong EPS outlook, high profitability, and reasonable peer valuation—making it a quality growth pick.",
                "category": "company",
                "datetime": 1791890504,
                "headline": "DexCom (NASDAQ:DXCM): Affordable Growth at a Reasonable Valuation"
              },
              {
                "id": 142590881,
                "url": "https://finnhub.io/api/news?id=ba7093e00631c7707b202bf2398be7f4422596333492cecab609d5b3e4179521",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Dexcom sees room to expand CGM adoption as low awareness, reimbursement hurdles and rising GLP-1 use create new opportunities in Type 2 diabetes.",
                "category": "company",
                "datetime": 1790949600,
                "headline": "DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care"
              },
              {
                "id": 142585580,
                "url": "https://finnhub.io/api/news?id=2d7c434e61282f2fffbfc2970ddcb7e273aa17972453f373514bd9ea283a7008",
                "image": "https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp",
                "source": "ChartMill",
                "related": "DXCM",
                "summary": "DexCom shows strong growth, top-tier profitability, and a constructive chart setup, making it a standout pick for growth screens with defined technical levels.",
                "category": "company",
                "datetime": 1790938834,
                "headline": "DexCom (NASDAQ:DXCM): Strong Growth Paired With a High-Quality Technical Setup"
              },
              {
                "id": 142389564,
                "url": "https://finnhub.io/api/news?id=ab4f9e99bbbeb3352d6984d2da00ffaa897b44bbcdf67afb376dbf86253e3dd1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom shares have delivered a mixed ride in recent years, and that uneven path raises a simple question for anyone looking at the chart today. Is the current US$87.47 price adequately supported by the cash the business is expected to generate over time? Over the past 5 years the stock has declined 36.0%, which puts the focus squarely on whether the cash flow story still lines up with the share price. The recent move to expand Jereme Sylvain’s remit to Chief Operating Officer as well as...",
                "category": "company",
                "datetime": 1790295609,
                "headline": "DexCom (DXCM) Stock Looks Cheap Based On Future Cash Flow"
              },
              {
                "id": 142370918,
                "url": "https://finnhub.io/api/news?id=7e80c34757dfb5e8e97506f9fb195de5bb917984d87162696be91d6a79a644bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom (DXCM) just reshuffled its leadership team, with longtime finance chief Jereme Sylvain stepping into a combined EVP and Chief Operating Officer role that now includes responsibility for global operations and quality. Recent boardroom moves at DexCom have arrived at a time when the 90-day share price return of 27.79% and year-to-date gain of 31.85% point to building momentum. However, the 1-year total shareholder return of 29.97% contrasts with a weaker 3-year record and a deeper 5-year...",
                "category": "company",
                "datetime": 1790224168,
                "headline": "Is DexCom (DXCM) Cheap After Its Leadership Reshuffle Or Already Fairly Priced?"
              },
              {
                "id": 142366064,
                "url": "https://finnhub.io/api/news?id=a735547d4009b8a6a2ff1c97ea29d07de4f3eb90a08524cdb3ae4c0418045a0a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom (NasdaqGS:DXCM) has promoted former Chief Financial Officer Jereme Sylvain to EVP and Chief Operating Officer. Healthcare executive Glenn S. Boehnlein has joined DexCom's board of directors, adding external industry experience to governance. The leadership shift, including Sylvain's promotion and Boehnlein's board appointment, deserves weighing alongside DexCom's broader fundamentals and risks. Take a look at 3 other big wins we have identified for DexCom. For readers looking to...",
                "category": "company",
                "datetime": 1790201622,
                "headline": "DexCom (DXCM) Promotes Former CFO Jereme Sylvain To Chief Operating Officer"
              }
            ],
            "raw_source": [
              {
                "id": 143001360,
                "url": "https://finnhub.io/api/news?id=f7c66dc28354acd25be69a90309b2a1e8c203a3e912a99dff08afa1a90670372",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Dublin, Oct. 19, 2026 (GLOBE NEWSWIRE) -- \"The Global Wearable Electronics Market 2026-2036\" has been added to ResearchAndMarkets.com's offering. The global wearable electronics market is undergoing a structural transformation as the industry expands beyond wrist-worn fitness trackers and smartwatches into extended reality, clinical-grade health monitoring, neural interfaces, smart textiles and AI-powered ambient computing. This evolution is positioning wearable technology as a critical interfac",
                "category": "company",
                "datetime": 1792402140,
                "headline": "Global Wearable Electronics Market Report 2026-2036 | AI, Extended Reality, and Digital Health Drive New Growth and Investment Opportunities"
              },
              {
                "id": 142967204,
                "url": "https://finnhub.io/api/news?id=42b6468e450f60825952736a03b4a6bc16025bc8b74f97295d39d5df3a62d661",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2096308178/image_2096308178.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DXCM",
                "summary": "DexCom (DXCM) stock outlook: G7 15-Day cuts CGM costs, lifts margins; NEJM CONNECT supports expansion.",
                "category": "company",
                "datetime": 1792280488,
                "headline": "DexCom: The 15-Day Sensor Lowered The Cost Curve Before The Type 2 Wave Arrives"
              },
              {
                "id": 142949300,
                "url": "https://finnhub.io/api/news?id=5f61ca8bc83cc6a5c59a63f0d916fd35413a564191aac5062b8c39970bef789d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "VASO is gaining from higher equipment deliveries, growing deferred commissions and a sharper healthcare focus, though partner dependence and margin pressures persist.",
                "category": "company",
                "datetime": 1792169520,
                "headline": "Vaso Stock Surges 149% in a Year: What's Behind the Rally?"
              },
              {
                "id": 142920652,
                "url": "https://finnhub.io/api/news?id=4d65b64a2191b0125df61c4b4e29ea9cac252789f02ebd64a622fcbe78e3eb55",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "The results come as Dexcom is awaiting a decision from the Centers for Medicare and Medicaid Services to expand Medicare coverage of the devices for people with Type 2 diabetes.",
                "category": "company",
                "datetime": 1792079617,
                "headline": "NEJM study supports CGM use for people with diabetes who don’t take insulin"
              },
              {
                "id": 142914169,
                "url": "https://finnhub.io/api/news?id=45e466476d944aaa59304ce5e17b91f9de13abdc33bda39579f837d9a3c671e3",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "DXCM",
                "summary": "Stay updated with the S&P500 stocks that are on the move in today's pre-market session.",
                "category": "company",
                "datetime": 1792067701,
                "headline": "These S&P500 stocks that are showing activity before the opening bell on Thursday."
              },
              {
                "id": 142888594,
                "url": "https://finnhub.io/api/news?id=cdd4ce3b33fa5fdc6d3866d2bda3d93869e7bbb137ac24183cb3cba5411619bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "SAN DIEGO, October 14, 2026--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced that results from the landmark CONNECT randomized controlled trial have been published in The New England Journal of Medicine (NEJM), providing rigorous evidence of the significant benefits of continuous glucose monitoring (CGM) for adults with Type 2 diabetes not on insulin.",
                "category": "company",
                "datetime": 1792012200,
                "headline": "Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin"
              },
              {
                "id": 142916768,
                "url": "https://finnhub.io/api/news?id=bbdee8d910331088f7dd1db48e3904360a99b21056596dba2f3ad52b98202c25",
                "image": "",
                "source": "Benzinga",
                "related": "DXCM",
                "summary": "Publication marks the first time in nearly two decades that The New England Journal of Medicine has published clinical data on standalone real-time continuous glucose monitoring (CGM) technology, dating back to the",
                "category": "company",
                "datetime": 1791998039,
                "headline": "DexCom's CONNECT Study Published In The New England Journal Of Medicine; Findings Support The Role Of CGM Earlier In Type 2 Diabetes Care For All People, Including Those Over The Age Of 65"
              },
              {
                "id": 142852679,
                "url": "https://finnhub.io/api/news?id=34290c97140591e6e2de505783946fa5ce70055d070f73382ae87ebf2fe12a4d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom's strong margins, G7 15-day rollout and promising pipeline support its growth outlook, but factory ramp-up costs, forex and input-price pressures pose risks.",
                "category": "company",
                "datetime": 1791909660,
                "headline": "Here's Why You Should Retain DexCom Stock in Your Portfolio for Now"
              },
              {
                "id": 142851324,
                "url": "https://finnhub.io/api/news?id=9a5ab20cb4cbe6ef7421907d4573d0026e3135f2a3f838748f56d3c15f63f45f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "388-Page Report Delivers 2025 Market Share Rankings, Vendor Valuation Metrics and End-User Buying Criteria as Asia Pacific Emerges as the Fastest-Growing RegionDublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"mHealth Solutions Market: Global Forecast to 2031\" has been added to ResearchAndMarkets.com's offering. Global mHealth Solutions Market to Reach USD 275.44 Billion by 2031 The global mHealth solutions market is projected to grow from USD 109.05 billion in 2026 to USD 275.44 billion by 2031, regis",
                "category": "company",
                "datetime": 1791904800,
                "headline": "mHealth Solutions Market Forecasts Growth from $109.05B (2026) to $275.44B by 2031, Profiling Philips, Medtronic, Abbott, Dexcom, ResMed & 20 Other Key Players"
              },
              {
                "id": 142846263,
                "url": "https://finnhub.io/api/news?id=0ee1d790ccd5098af623c3ed88bba15b9275f4278cb312b8c59a33d19b6a039b",
                "image": "https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp",
                "source": "ChartMill",
                "related": "DXCM",
                "summary": "DexCom (DXCM) offers affordable growth with strong EPS outlook, high profitability, and reasonable peer valuation—making it a quality growth pick.",
                "category": "company",
                "datetime": 1791890504,
                "headline": "DexCom (NASDAQ:DXCM): Affordable Growth at a Reasonable Valuation"
              },
              {
                "id": 142852680,
                "url": "https://finnhub.io/api/news?id=ce0e4eccf454ba4714910d79b62bee318e3c6e0ecff3211cb04471c80dddd62a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom will unveil its third-quarter results soon, with analysts expecting EPS to post a high-single-digit year-over-year gain.",
                "category": "company",
                "datetime": 1791887242,
                "headline": "Here's What to Expect From DexCom’s Next Earnings Report"
              },
              {
                "id": 142823759,
                "url": "https://finnhub.io/api/news?id=e3819c91fe7811c283e452fd9b1368d8c6b09375e90df6db0a0e8e1bb69d3588",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Ascensia also struck an exclusive sales agreement with Sava, which is making a wearable to continuously monitor glucose and other biomarkers.",
                "category": "company",
                "datetime": 1791828469,
                "headline": "Ascensia leads $36M funding round for glucose sensor startup"
              },
              {
                "id": 142821026,
                "url": "https://finnhub.io/api/news?id=62d54c018ab8df0fc2a00e552f8bc8a027542428bf17eefaa01aba67a5c6137e",
                "image": "",
                "source": "Benzinga",
                "related": "DXCM",
                "summary": "BTIG  analyst Ryan Zimmerman   maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $90 to $96.",
                "category": "company",
                "datetime": 1791784650,
                "headline": "BTIG Maintains Buy on DexCom, Raises Price Target to $96"
              },
              {
                "id": 142729415,
                "url": "https://finnhub.io/api/news?id=9440243e0030fc04bd6e204e986fb54135146e4f4ae446b21880be786f46d371",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2266925511/image_2266925511.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DXCM",
                "summary": "Senseonics's Eversense 365 CGM drives sales and margin gains, but adoption, funding, dilution, and valuation risks remain. Click here for more on SENS stock.",
                "category": "company",
                "datetime": 1791457252,
                "headline": "Senseonics: Eversense 365 Adoption Has To Earn The Valuation"
              },
              {
                "id": 142715419,
                "url": "https://finnhub.io/api/news?id=120b1543838e5287b095994b13133c00c30e13f579185f73efa35719c0fcf639",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Investing.com-- Citi reiterated its top picks in the medtech sector, highlighting Abbott Laboratories and Dexcom as standout opportunities while pointing to diverging fortunes across the industry.",
                "category": "company",
                "datetime": 1791445230,
                "headline": "Citi reiterates these 2 medtech stocks as its top picks in the sector"
              },
              {
                "id": 140420211,
                "url": "https://finnhub.io/api/news?id=c9045c53ac19ad80d94a07c2e8320fa134ac76c18ad5824d79898864952688d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Intel downgraded, Marvell upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1791381613,
                "headline": "Intel downgraded, Marvell upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 142695140,
                "url": "https://finnhub.io/api/news?id=3f9e51ecf2dd8a07811fc127907647b7a8e864b673d1d0ab62f166ee133c497b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "SAN DIEGO, October 07, 2026--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2026 financial results after market close on Thursday, October 29, 2026. Management will hold a conference call to review the company's third quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and wil",
                "category": "company",
                "datetime": 1791376200,
                "headline": "Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time"
              },
              {
                "id": 142694515,
                "url": "https://finnhub.io/api/news?id=61a0e8e64a691503bebcb0912945f725aef32ce300a43f33b7675d32fb01f514",
                "image": "",
                "source": "Benzinga",
                "related": "DXCM",
                "summary": "Barclays  analyst Christopher Pasquale   initiates coverage on DexCom (NASDAQ:DXCM) with a Overweight rating and announces Price Target of $115.",
                "category": "company",
                "datetime": 1791362257,
                "headline": "Barclays Initiates Coverage On DexCom with Overweight Rating, Announces Price Target of $115"
              },
              {
                "id": 142667425,
                "url": "https://finnhub.io/api/news?id=799cd2ca19736d45c52db9faa5f9160ef65f2f81c348e1bda7366c44deea05c5",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "DXCM",
                "summary": "Curious about the top performers within the S&P500 index one hour before the close of the markets on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
                "category": "company",
                "datetime": 1791313501,
                "headline": "Uncover the latest developments among S&P500 stocks in today's session."
              },
              {
                "id": 142666223,
                "url": "https://finnhub.io/api/news?id=77d86f15549f5f68cb794b92dd883f9ce67028af48767f3a173cdb7c589f7e8d",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "DXCM",
                "summary": "Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.",
                "category": "company",
                "datetime": 1791304502,
                "headline": "Which S&P500 stocks are moving on Tuesday?"
              },
              {
                "id": 142664476,
                "url": "https://finnhub.io/api/news?id=293a1e63d2d9f8d35ccf43537079ef2352e40d44a0deea52ecbe4d188ab55d23",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "DXCM",
                "summary": "Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.",
                "category": "company",
                "datetime": 1791297302,
                "headline": "Tuesday's session: gap up and gap down stock in the S&P500 index"
              },
              {
                "id": 142663348,
                "url": "https://finnhub.io/api/news?id=a6617184e8614d18c4e049a30a1e65168f20cba5268ff8e7ac0001f934e8094a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "SAN DIEGO, October 06, 2026--DEXCOM, INC. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fifth season of Dexcom U, the company’s one-of-a-kind NIL (Name, Image and Likeness) program exclusively for college athletes with diabetes.",
                "category": "company",
                "datetime": 1791291600,
                "headline": "Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading"
              },
              {
                "id": 142662618,
                "url": "https://finnhub.io/api/news?id=d78ffd39021735e4739cfbbd4e7ce2c89bcdbad94ff4f003fc44637d8d221831",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/05/Nasdaq-Inscription-Next-To-Us-Dollars--T.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DXCM",
                "summary": "The Nasdaq 100 trades at records Monday, yet 55 of its 101 stocks sit below their 50-day average. QQQ has beaten equal-weight QQQE by 8% since late July.",
                "category": "company",
                "datetime": 1791212429,
                "headline": "Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average"
              },
              {
                "id": 142593627,
                "url": "https://finnhub.io/api/news?id=e0173b4c7ee26a0903ee9dd4e406e9e6fbbe0c3f2aed758ce432e74a02167ae4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "The tax-free exchange offer allows Medtronic investors to swap their shares for MiniMed shares held by Medtronic in what Wall Street calls a split-off.",
                "category": "company",
                "datetime": 1790969220,
                "headline": "Why Medtronic’s $4 Billion MiniMed Exchange Offer Is Losing Its Allure"
              },
              {
                "id": 142590881,
                "url": "https://finnhub.io/api/news?id=ba7093e00631c7707b202bf2398be7f4422596333492cecab609d5b3e4179521",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Dexcom sees room to expand CGM adoption as low awareness, reimbursement hurdles and rising GLP-1 use create new opportunities in Type 2 diabetes.",
                "category": "company",
                "datetime": 1790949600,
                "headline": "DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care"
              },
              {
                "id": 142585580,
                "url": "https://finnhub.io/api/news?id=2d7c434e61282f2fffbfc2970ddcb7e273aa17972453f373514bd9ea283a7008",
                "image": "https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp",
                "source": "ChartMill",
                "related": "DXCM",
                "summary": "DexCom shows strong growth, top-tier profitability, and a constructive chart setup, making it a standout pick for growth screens with defined technical levels.",
                "category": "company",
                "datetime": 1790938834,
                "headline": "DexCom (NASDAQ:DXCM): Strong Growth Paired With a High-Quality Technical Setup"
              },
              {
                "id": 142559193,
                "url": "https://finnhub.io/api/news?id=812cfe927ad3b20dfaa6c08de5b0ee99d362dbe3827d3ed9bc34cb58493c0cd4",
                "image": "",
                "source": "Benzinga",
                "related": "DXCM",
                "summary": "RBC Capital  analyst Kendall Au   maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $90 to $105.",
                "category": "company",
                "datetime": 1790845460,
                "headline": "RBC Capital Maintains Outperform on DexCom, Raises Price Target to $105"
              },
              {
                "id": 142528965,
                "url": "https://finnhub.io/api/news?id=3d0b711b2e9b6404d0d6297a5d921fd7c1d14912a9cd025a8eabbf411d6f99e1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Tandem Diabetes Care has recently launched its Tandem Mobi automated insulin delivery system in 12 countries across Europe and Israel, using Dexcom G7 continuous glucose monitoring and Control-IQ+ technology to automatically adjust insulin every 5 minutes. The international rollout of this small, iPhone-controlled pump with flexible wear options and a 200-unit cartridge broadens Tandem’s technology ecosystem for people living with diabetes outside the United States. We’ll now explore how...",
                "category": "company",
                "datetime": 1790817776,
                "headline": "Tandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump System"
              },
              {
                "id": 142498271,
                "url": "https://finnhub.io/api/news?id=c8a3883a0d743ae06ec3b632acdcbfbf365a4abeaa0485104c7b26b8a525f462",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "BBNX's Eversense 365 partnership is likely to broaden CGM choice and strengthen its automated insulin delivery ecosystem across iLet and mint.",
                "category": "company",
                "datetime": 1790690760,
                "headline": "Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal"
              },
              {
                "id": 142471977,
                "url": "https://finnhub.io/api/news?id=9a9e8c90864916b48c6ae5ca4c5a7b7e7529ccc85f497dba335c6b61d6fd5ef0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Glucose monitoring company DexCom’s investment in Oura values the company at just over $5 billion. Oura is looking to go public at a valuation above $15 billion.",
                "category": "company",
                "datetime": 1790627760,
                "headline": "This Stock Could Be the Big Winner Out of Oura’s IPO"
              },
              {
                "id": 142467285,
                "url": "https://finnhub.io/api/news?id=3769358d3e460e01434eddeed80016e677e5f20103e739e42ecba5af01f9f33d",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/28/Stock-market-chart--representative-image.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DXCM",
                "summary": "Market Overview\n\n\n\nStocks began their breakout to new all-time highs again, but it remains a highly selective environment. Only the Nasdaq hit a record high, as it finished up 2.06% on the week, and outperformed for the",
                "category": "company",
                "datetime": 1790585196,
                "headline": "The Insider Report: The Leaders Have Taken Off"
              },
              {
                "id": 142460907,
                "url": "https://finnhub.io/api/news?id=a57368bc532321048255f0eef4d920cdc87da7fdf7b0ffdeef89f459559e6839",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "MILAN, September 28, 2026--The Tandem Mobi automated insulin delivery system with Control-IQ+ automated insulin delivery technology is now available in 12 international markets.",
                "category": "company",
                "datetime": 1790578800,
                "headline": "Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets"
              },
              {
                "id": 142460906,
                "url": "https://finnhub.io/api/news?id=d7a5888e163f7e34cadd3d2f283f60b4d3498bf33975189d23da7e00b1acf7e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "MILAN, September 28, 2026--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today released its \"Dexcom State of Type 2 Report: Global Access and Attitudes to Diabetes Technology\" in advance of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28-Oct. 2. The company also announced a partnership to become the official continuous glucose monitor of Team Novo Nordisk.",
                "category": "company",
                "datetime": 1790575200,
                "headline": "Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care"
              },
              {
                "id": 142467762,
                "url": "https://finnhub.io/api/news?id=b6dca09324250ed8938c3bd363d9f85be70e0d34f6d15f85c4c20ae05dfa6950",
                "image": "",
                "source": "Benzinga",
                "related": "DXCM",
                "summary": "New global State of Type 2 Report uncovers three interconnected challenges in Type 2 diabetes care: health literacy, technology literacy and systemic access.1New partnership reinforces Dexcom’s commitment to advancing",
                "category": "company",
                "datetime": 1790565474,
                "headline": "Dexcom Becomes Team Novo Nordisk's Official CGM Partner, Releases Report Citing Three Type 2 Care Challenges Across Eight Countries"
              },
              {
                "id": 142421217,
                "url": "https://finnhub.io/api/news?id=73eb6ea9964792dd56d2fb2b2f2942337fa260c9cdd64aea611f01d6a23dcd60",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.",
                "category": "company",
                "datetime": 1790336197,
                "headline": "2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds"
              },
              {
                "id": 142389564,
                "url": "https://finnhub.io/api/news?id=ab4f9e99bbbeb3352d6984d2da00ffaa897b44bbcdf67afb376dbf86253e3dd1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom shares have delivered a mixed ride in recent years, and that uneven path raises a simple question for anyone looking at the chart today. Is the current US$87.47 price adequately supported by the cash the business is expected to generate over time? Over the past 5 years the stock has declined 36.0%, which puts the focus squarely on whether the cash flow story still lines up with the share price. The recent move to expand Jereme Sylvain’s remit to Chief Operating Officer as well as...",
                "category": "company",
                "datetime": 1790295609,
                "headline": "DexCom (DXCM) Stock Looks Cheap Based On Future Cash Flow"
              },
              {
                "id": 142370918,
                "url": "https://finnhub.io/api/news?id=7e80c34757dfb5e8e97506f9fb195de5bb917984d87162696be91d6a79a644bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom (DXCM) just reshuffled its leadership team, with longtime finance chief Jereme Sylvain stepping into a combined EVP and Chief Operating Officer role that now includes responsibility for global operations and quality. Recent boardroom moves at DexCom have arrived at a time when the 90-day share price return of 27.79% and year-to-date gain of 31.85% point to building momentum. However, the 1-year total shareholder return of 29.97% contrasts with a weaker 3-year record and a deeper 5-year...",
                "category": "company",
                "datetime": 1790224168,
                "headline": "Is DexCom (DXCM) Cheap After Its Leadership Reshuffle Or Already Fairly Priced?"
              },
              {
                "id": 142366064,
                "url": "https://finnhub.io/api/news?id=a735547d4009b8a6a2ff1c97ea29d07de4f3eb90a08524cdb3ae4c0418045a0a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom (NasdaqGS:DXCM) has promoted former Chief Financial Officer Jereme Sylvain to EVP and Chief Operating Officer. Healthcare executive Glenn S. Boehnlein has joined DexCom's board of directors, adding external industry experience to governance. The leadership shift, including Sylvain's promotion and Boehnlein's board appointment, deserves weighing alongside DexCom's broader fundamentals and risks. Take a look at 3 other big wins we have identified for DexCom. For readers looking to...",
                "category": "company",
                "datetime": 1790201622,
                "headline": "DexCom (DXCM) Promotes Former CFO Jereme Sylvain To Chief Operating Officer"
              },
              {
                "id": 142364255,
                "url": "https://finnhub.io/api/news?id=895685be22cd87859303846feda7f64760fc0297ce940d33c824aa0414d154ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Oura's IPO targets a $12.8B-$14.1B valuation, pricing shares at $40-$44 ahead of its Nasdaq debut, backed by Eli Lilly interest and strong subscription revenue growth.",
                "category": "company",
                "datetime": 1790101500,
                "headline": "Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring"
              },
              {
                "id": 142310755,
                "url": "https://finnhub.io/api/news?id=92eed5103bf0ea374a58ca1e7b576333d065b92ab5af27bca906a641b348f8df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like profitability concerns, rising costs, or shifts in market trends.",
                "category": "company",
                "datetime": 1789988065,
                "headline": "2 Nasdaq 100 Stocks for Long-Term Investors and 1 We Turn Down"
              },
              {
                "id": 142307394,
                "url": "https://finnhub.io/api/news?id=7bc174f162091d9036397952184db2de41e5e61e125e11ffded05e0f7cc529bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Dublin, Sept. 21, 2026 (GLOBE NEWSWIRE) -- \"Wearable Biosensors Market - Global Forecast to 2036\" has been added to ResearchAndMarkets.com's offering.According to the research report, the global wearable biosensors market is projected to reach USD 105.5 billion by 2036 from USD 35.5 billion in 2026, growing at a CAGR of 12.5% during the forecast period (2026-2036). The growth of this market is primarily driven by the escalating demand for continuous health monitoring, the rising prevalence of ch",
                "category": "company",
                "datetime": 1789981440,
                "headline": "Global Wearable Biosensors Market Trends, Strategies and Forecast to 2036 Featuring Abbott Labs, Dexcom, Medtronic, Roche, Apple, Samsung Electronics Co., Garmin and Other Key Players"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 6,
            "negative_hits": 0,
            "positive_hits": 5,
            "recomputed_at_score": true,
            "sentiment_score_raw": 2,
            "source_article_count": 41,
            "discarded_article_count": 35
          },
          "sentimentPoints": 8
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.3,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1,
          "macdPoints": 3.2,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1,
            "vcp_reason": "跌縮量(近10日4日)；靠近20日高位；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 3975363.3333333335,
              "down_days": 5,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 3513690,
              "avg_vol_20": 3444765,
              "avg_vol_30": 3975363.3333333335,
              "range_pct_10": 0.06989997673877651,
              "range_pct_20": 0.08757850662944872,
              "range_pct_30": 0.09420795533845074,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8838663803476243,
              "dist_to_20d_high": 0.04878858280783269,
              "down_shrink_days": 4,
              "breakout_level_20d": 90.39,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.7419753086419765
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.792975110490812,
              "turnoverUsdM": 220.12376052000002,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.DXCM",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 81.1772,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2,
              "rsi_score": 1,
              "macd_score": 2.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 5.6,
            "take_profit_price": 90.6187,
            "target_multiplier": 1.9,
            "technical_strength": 1.53,
            "take_profit_percent": 5.4
          },
          "positionPoints": 1.4,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.585950220981624,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 2.4014,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.79
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "弱勢",
      "score": 4,
      "value": -3.98
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0064
    },
    "kdj": {
      "d": 47.42,
      "j": 63.26,
      "k": 52.7,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 43.04
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 53102626,
      "recentSlope": -254587.4,
      "previousSlope": -1661970
    },
    "rsi": 48.15,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 83.1968,
      "position": "SAR喺價下",
      "distancePct": 3.24,
      "previousTrend": "上升"
    },
    "ma50": 87.5702,
    "macd": {
      "macd": -0.2800148726945082,
      "trend": "看漲",
      "signal": -0.3592759630752472,
      "histogram": 0.07926109038073897
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 86.2538,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.75,
      "score": 2,
      "avgVolume": 3396979,
      "currentVolume": 2560174
    },
    "derived": {
      "ma20": 85.992,
      "ma50": 87.5702,
      "prevClose": 86.04,
      "avgVolume10": 3461817,
      "avgVolume20": 3396979,
      "changePercent": -0.07,
      "avgVolumeForScore": 3396979
    },
    "ma_cross": {
      "ma20": 85.992,
      "ma50": 87.5702,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 86.1515,
      "prevMa50": 87.5456,
      "spreadPct": 1.8,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 82.9508,
      "upper": 89.0332,
      "position": "中間"
    },
    "rsi_short": 59.14,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.75
    }
  }
}

{
  "close": 85.98,
  "volume": 2560174,
  "changePercent": -0.07
}